Russell Investments Group
CADL icon

Russell Investments Group’s Candel Therapeutics CADL Stock Holding History

Russell Investments Group’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165K Buy
16,007
+12,307
+333% +$93K ﹤0.01% 3252
2026
Q1 		$18.1K Sell
3,700
-463
-11% -$2.52K ﹤0.01% 3648
2025
Q4 		$23.5K Buy
4,163
+905
+28% +$4.87K ﹤0.01% 3573
2025
Q3 		$16.6K Buy
+3,258
New +$18.8K ﹤0.01% 3647
2025
Q2 		– Sell
-4,732
Closed -$26.7K – 3856
2025
Q1 		$26.7K Buy
4,732
+979
+26% +$8K ﹤0.01% 3048
2024
Q4 		$32.6K Buy
3,753
+1,610
+75% +$9.51K ﹤0.01% 2917
2024
Q3 		$14.9K Buy
+2,143
New +$13.3K ﹤0.01% 3016

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Russell Investments Group's CADL Position: Q2 2026 in Review

Russell Investments Group increased its Candel Therapeutics (CADL) stake by 333% in Q2 2026, buying an estimated $93K and bringing the position to 16,007 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #3252.

Russell Investments Group first reported a position in CADL in Q3 2024 and has held it in 7 quarters since. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Russell Investments Group held 16,007 shares of Candel Therapeutics worth $165K as of Q2 2026.
  • Russell Investments Group bought 12,307 Candel Therapeutics shares in Q2 2026, an estimated $93K.
  • Candel Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3252 holding.
  • Russell Investments Group first reported a position in Candel Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.